SCP
RCPI

Seizert Capital Partners’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Seizert Capital Partners’s Portfolio RCPI Stock Details RCPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-3,844
Closed -$10K – 222
2015
Q1 		$10K Hold
3,844
– – ﹤0.01% 208
2014
Q4 		$17K Buy
3,844
+1,140
+42% +$6K ﹤0.01% 212
2014
Q3 		$19K Buy
2,704
+1,320
+95% +$13K ﹤0.01% 206
2014
Q2 		$20K Buy
+1,384
New +$24K ﹤0.01% 208

Other funds holding RCPI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Seizert Capital Partners's RCPI Position: Q2 2015 in Review

Seizert Capital Partners sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q2 2015, closing a stake of 3,844 shares — an estimated $10K sold.

Seizert Capital Partners first reported a position in RCPI in Q2 2014 and held it in 4 quarters. The position peaked at $20K in Q2 2014. 36 funds tracked by Wall St. Rank hold RCPI as of Q2 2015.

  • Seizert Capital Partners reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Seizert Capital Partners sold 3,844 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $10K.
  • Seizert Capital Partners first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 4 quarters.
  • Seizert Capital Partners's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $20K in Q2 2014.
  • 36 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Seizert Capital Partners's 13F filing for Q2 2015, filed 6 Aug 2015.